Cargando…
Immunotherapy: Review of the Existing Evidence and Challenges in Breast Cancer
SIMPLE SUMMARY: Breast cancer is one of the most common malignant tumors in women. Its incidence rate accounts for 7–10% of all kinds of malignant tumors in the whole body, second only to uterine cancer in women, and has become the main cancer threatening women’s health. Fortunately, it has been pro...
Autores principales: | Hu, Yun, Li, Yan, Yao, Zhangcheng, Huang, Fenglin, Cai, Hongzhou, Liu, Hanyuan, Zhang, Xiaoyi, Zhang, Junying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913569/ https://www.ncbi.nlm.nih.gov/pubmed/36765522 http://dx.doi.org/10.3390/cancers15030563 |
Ejemplares similares
-
Extracellular RNA in melanoma: Advances, challenges, and opportunities
por: Li, Zhouxiao, et al.
Publicado: (2023) -
Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy
por: Li, Guan-Zhang, et al.
Publicado: (2019) -
Exosomes exist in nipple discharge of breast cancer
por: Wang, Ya-Wen, et al.
Publicado: (2020) -
Challenging management dogma where evidence is non-existent, weak or outdated
por: Hofmaenner, Daniel A., et al.
Publicado: (2022) -
Tegaserod Maleate Inhibits Breast Cancer Progression and Enhances the Sensitivity of Immunotherapy
por: Li, Xiao, et al.
Publicado: (2022)